The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market

1. Global Sexually
Transmitted Disease (STD)
Diagnostics Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Sexually Transmitted
Disease (STD) Diagnostics Market: Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2024-2032," the global sexually
transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion
in 2023.
Sexually transmitted disease (STD) diagnostics refers to scientific tools and
techniques used to identify, detect, and confirm the presence of STDs in an
individual. It includes polymerase chain reaction (PCR) tests, nucleic acid
amplification tests (NAATs), enzyme-linked immunosorbent assays (ELISAs),
point-of-care (PoC) devices, and self-testing kits. STD diagnostics utilize
blood, urine, genital swab, and fluid samples to detect the presence of
pathogens and markers related to STDs.
It is widely used to diagnose chlamydia, syphilis, gonorrhea, herpes, hepatitis
B and C, human immunodeficiency virus (HIV), and human papillomavirus
(HPV). STD diagnostics are highly efficient and accurate techniques that aid in
the early detection of infections, enable timely intervention, prevent future
complications, and increase patient outcomes.
Request for a PDF sample of this report:
https://www.imarcgroup.com/sexually -transmitted-disease-diagnostics-
market/requestsample

4. Report Description
Global Sexually Transmitted Disease (STD) Diagnostics Market Trends:
The rising prevalence of STDs due to unprotected sexual intercourse and drug abuse is one of the key factors propelling
the market growth. STD diagnostics are widely used to determine the severity of infections, prevent further transmission,
and identify potential treatment options to improve patient outcomes. Furthermore, the growing awareness among the
masses regarding early disease detection to avoid various future complications, such as cancer, congenital disabilities,
and infertility, is acting as another growth-inducing factor. Additionally, the recent development of multiplex assays,
which allows simultaneous detection of multiple STD pathogens in a single test, thus, reducing costs, saving time, and
improving diagnostic accuracy, is positively inf luencing the market growth.
Besides this, the introduction of self-testing kits that allow individuals to conveniently test the presence of STDs in their
homes without visiting healthcare facilities, which aids in improving accessibility, enhancing patient comfort, and
maintaining privacy, is providing an impetus to the market growth. Apart from this, the implementation of supportive
government policies to educate the masses about STDs, promote early detection, and provide access to high-qualit y
treatment and testing facilities is contributing to the market growth. Other factors, including rising healthcare
expenditure, increasing investment in the development of advanced diagnostic tools, and growing emphasis on sexual
health among the masses, are anticipated to drive the market growth.
Looking forward, the market is expected to reach US$ 159.5 Billion by 2032, exhibiting a CAGR of 4.71%
during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/sexually-transmitted-disease-
diagnostics-market

5. Report
Segmentation
Type Insights:
• Chlamydia Testing
• Syphilis Testing
• Gonorrhea Testing
• Herpes Simplex Virus Testing
• Human Papilloma Virus Testing
• Human Immunodeficiency Virus Testing
• Chancroid Testing
• Others
Device Type Insights:
• Laboratory Devices
o Thermal Cycler – PCR
o Lateral Flow Readers
o Flow Cytometers
o Absorbance Microplate Reader –
Enzyme Linked Immunosorbent Assay
(ELISA)

6. Report
Segmentation
o Others
• Point of Care (PoC) Devices
o Phone Chips (Microfluidics + ICT)
o Portable/Bench Top/Rapid Diagnostic
Kits
End User Insights:
• Laboratory Testing
• Point of Care (PoC) Testing
Regional Insights:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Abbott Laboratories
• Becton Dickinson and Company
• BioMérieux SA
• Bio-Rad Laboratories Inc.
• Cepheid (Danaher Corporation)
• F. Hoffmann-La Roche AG
• Hologic Inc., Qiagen N.V.
• Quidel Corporation
• Siemens Healthineers AG (Siemens AG)

8. Key Questions
Answered in
the Report
How has the global sexually transmitted disease (STD) diagnostics
market performed so far, and how will it perform in the coming
years?
What are the drivers, restraints, and opportunities in the global
sexually transmitted disease (STD) diagnostics market?
What is the impact of each driver, restraint, and opportunity on the
global sexually transmitted disease (STD) diagnostics market?
What are the key regional markets?
Which countries represent the most attractive sexually transmitted
disease (STD) diagnostics market?
What is the breakup of the market based on the type?
Which is the most attractive type in the sexually transmitted
disease (STD) diagnostics market?

9. Key Questions
Answered in
the Report
What is the breakup of the market based on the device type?
Which is the most attractive device type in the sexually transmitted
disease (STD) diagnostics market?
What is the breakup of the market based on end user?
Which is the most attractive end user in the sexually transmitted
disease (STD) diagnostics market?
What is the competitive structure of the global sexually transmitted
disease (STD) diagnostics market?
Who are the key players/companies in the global sexually
transmitted disease (STD) diagnostics market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sexually Transmitted Disease (STD)
Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Chlamydia Testing
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Syphilis Testing
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 Gonorrhea Testing
6.3.1 Mark et Trends
6.3.2 Mark et Forecast

11. Table of
Contents
6.4 Herpes Simplex Virus Testing
6.4.1 Mark et Trends
6.4.2 Mark et Forecast
6.5 Human Papilloma Virus Testing
6.5.1 Mark et Trends
6.5.2 Mark et Forecast
6.6 Human Immunodeficiency Virus Testing
6.6.1 Mark et Trends
6.6.2 Mark et Forecast
6.7 Chancroid Testing
6.7.1 Mark et Trends
6.7.2 Mark et Forecast
6.8 Others
6.8.1 Mark et Trends
6.8.2 Market Forecast
7 Market Breakup by Device Type
7.1 Laboratory Devices
7.1.1 Mark et Trends
7.1.2 Key Segments
7.1.2.1 Thermal Cyclers - PCR
7.1.2.2 Lateral Flow Readers
7.1.2.3 Flow Cytometers
7.1.2.4 Absorbance Microplate Reader - Enzyme
Linked Immunosorbent Assay (ELISA)
7.1.2.5 Others
7.1.3 Mark et Forecast
7.2 Point of Care (PoC) Devices
7.2.1 Mark et Trends
For more information, visit :
https://www.imarcgroup.com/sexually -transmitted-disease-
diagnostics-market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com